182 related articles for article (PubMed ID: 2457249)
1. [Tumor markers].
Cappelaere P
Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
[No Abstract] [Full Text] [Related]
2. Serum tumor markers.
Klee GG; Go VL
Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
[No Abstract] [Full Text] [Related]
3. [Course studies by means of tumor markers].
Quentmeier A
Aktuelle Probl Chir Orthop; 1980; 74():43-6. PubMed ID: 6156606
[No Abstract] [Full Text] [Related]
4. [Sense and nonsense of tumor markers in practice].
Joss R; Cerny T
Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers: value and limitations in the management of cancer patients.
Bates SE; Longo DL
Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
[TBL] [Abstract][Full Text] [Related]
6. Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S; Miyake H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
[No Abstract] [Full Text] [Related]
7. [Gastric cancer with bone metastasis from the viewpoint on oncodevelopmental gene products].
Ohyama S; Yonemura Y; Hashimoto T; Sawa T; Miwa K; Miyazaki I
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):1013-9. PubMed ID: 2447212
[No Abstract] [Full Text] [Related]
8. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
[TBL] [Abstract][Full Text] [Related]
9. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
Bellet D; Bidart JM
Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
[No Abstract] [Full Text] [Related]
10. Enhanced detection systems for enzyme-linked heterogeneous immunoassays: luminescence.
Edwards JC; Moon CR
Immunol Ser; 1990; 53():95-106. PubMed ID: 1713073
[TBL] [Abstract][Full Text] [Related]
11. Biological markers of human tumors and monitoring of cancer treatment.
Tanneberger S; Nissen E; Ziegenbein R
Arch Geschwulstforsch; 1979; 49(6):528-34. PubMed ID: 94534
[TBL] [Abstract][Full Text] [Related]
12. Advances in the use of tumor markers.
Schwartz MK
Compr Ther; 1990 Nov; 16(11):51-7. PubMed ID: 1702695
[No Abstract] [Full Text] [Related]
13. Tumour markers.
Pandha HS; Waxman J
QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a seminoma cell-line (S2).
von Keitz AT; Riedmiller H; Neumann K; Gutschank W; Fonatsch C
Investig Urol (Berl); 1994; 5():28-31. PubMed ID: 7536523
[No Abstract] [Full Text] [Related]
15. [Tumor markers--possibilities and limitations].
Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G
Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136
[No Abstract] [Full Text] [Related]
16. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients].
Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG
Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514
[TBL] [Abstract][Full Text] [Related]
17. Tumor markers. Key pieces to your cancer patient's clinical picture.
Ostchega Y; Culnane M
Nursing; 1985 Sep; 15(9):48-51. PubMed ID: 2410836
[No Abstract] [Full Text] [Related]
18. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
Wählby L
Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
[No Abstract] [Full Text] [Related]
19. The clinical usefulness and limitations of tumor markers.
Torosian MH
Surg Gynecol Obstet; 1988 Jun; 166(6):567-79. PubMed ID: 2453934
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of present tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
